Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-543-6420
Dr. Baik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2002 - 2005
University of Rochester School of Medicine and DentistryClass of 2002
Certifications & Licensure
WA State Medical License 2011 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer Start of enrollment: 2012 Dec 02
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsA Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve-Mutant Metastatic Non-Small Cell Lung...Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn
Journal of Clinical Oncology. 2025-02-01 - 1 citationsAmivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A.Benjamin Besse, Koichi Goto, Yongsheng Wang, Se-Hoon Lee, Melina E Marmarelis
Journal of Thoracic Oncology. 2025-01-02 - 14 citationsTelisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous-Wildtype Non-Small Cell Lung Cancer in the Phas...D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Goldman, Fedor Moiseenko
Journal of Clinical Oncology. 2024-09-01
Journal Articles
- Trastuzumab Emtansine (T-dM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety and BiomarkersAugusto Villegas, Christina S Baik, Clinical Cancer Research
Press Mentions
Seeking to Expand Targeted Therapy for Lung CancerAugust 9th, 2021- Clinical Oncology Findings from Seattle Cancer Care Alliance (SCCA) Clinicians to Be Featured at the 2021 ASCO Annual MeetingJune 3rd, 2021
- Phase III Trial Reports Chemoimmunotherapy Is Superior to Chemotherapy Alone in Malignant Pleural MesotheliomaSeptember 7th, 2023
- Join now to see all
Professional Memberships
- Member
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
